ExodusPoint Capital Management »

Fate Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $282k 81k 3.50
2023-09-30 $40k 19k 2.10
2023-06-30 $115k 24k 4.74
2023-03-31 $554k 97k 5.70
2022-12-31 $2.5M 246k 10.09
2022-09-30 $571k 26k 22.42
2021-09-30 $811k 14k 59.26
2021-06-30 $870k 10k 86.83
2020-12-31 $1.2M 14k 90.91
2020-03-31 $267k 12k 22.22

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Johnson & Johnson Put Option (JNJ)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
NiSource (NI)
CMS Energy Corporation (CMS)
PPL Corporation (PPL)
Tesla Motors Put Option (TSLA)
Mondelez Intl Cl A (MDLZ)
Becton, Dickinson and (BDX)
Exelon Corporation (EXC)

View all positions for ExodusPoint Capital Management

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
BlackRock
BlackRock
Deep Track Capital
State Street Corporation
Boxer Capital
Bellevue Group
Citadel Advisors
Deerfield Management Company
Johnson & Johnson
D. E. Shaw & Co
Morgan Stanley
Woodline Partners
Baker Bros. Advisors

View all funds holding Fate Therapeutics